(Q46363086)

21 December 2017

title

Rosuvastatin and vascular dysfunction markers in pulmonary arterial hypertension: a placebo-controlled study (English)

1 reference

21 December 2017

1 reference

arterial hypertension

1 reference

A C Barreto

1

1 reference

21 December 2017

N Y Maeda

2

1 reference

21 December 2017

R P S Soares

3

1 reference

21 December 2017

C Cícero

4

1 reference

21 December 2017

A A Lopes

5

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

21 December 2017

Brazilian Journal of Medical and Biological Research

published in

1 reference

21 December 2017

volume

41

1 reference

21 December 2017

issue

8

1 reference

21 December 2017

page(s)

657-663

1 reference

21 December 2017

A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Inhaled iloprost for severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Sitaxsentan therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Endothelial dysfunction in pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Simvastatin enhances bone morphogenetic protein receptor type II expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Rosuvastatin: a new inhibitor of HMG-coA reductase for the treatment of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Rosuvastatin in the management of hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Attenuation of chronic hypoxic pulmonary hypertension by simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

Increased levels of soluble P-selectin in hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2008000800003

10.1590/S0100-879X2008000800003

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017